Clinical trial
Prevention of Early Mortality by Presumptive TB Treatment in HIV-infected Patients Initiating Antiretroviral Therapy
NCT01417988 is registered in ClinicalTrials.gov with Prof JMA Lange as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Early Mortality by Presumptive TB Treatment in HIV-infected Patients Initiating Antiretroviral Therapy
- Lead sponsor
- Prof JMA Lange
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- August 31, 2011
- Completion date
- June 30, 2013
- Enrollment
- 44 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection, tuberculosis